TY - JOUR
T1 - Practices, attitudes, and confidence related to tobacco treatment interventions in HIV clinics
T2 - A multisite cross-sectional survey
AU - Bold, Krysten W.
AU - Deng, Yanhong
AU - Dziura, James
AU - Porter, Elizabeth
AU - Sigel, Keith M.
AU - Yager, Jessica E.
AU - Ledgerwood, David M.
AU - Bernstein, Steven L.
AU - Edelman, E. Jennifer
N1 - Publisher Copyright:
© 2022 Society of Behavioral Medicine. All rights reserved.
PY - 2022/6/1
Y1 - 2022/6/1
N2 - Tobacco use disorder (TUD) is a major threat to health among people with HIV (PWH), but it is often untreated. Among HIV clinicians and staff, we sought to characterize practices, attitudes, and confidence addressing TUD among PWH to identify potential opportunities to enhance provision of care. Cross-sectional deidentified, web-based surveys were administered from November 4, 2020 through December 15, 2020 in HIV clinics in three health systems in the United States Northeast. Surveys assessed provider characteristics and experience, reported practices addressing tobacco use, and knowledge and attitudes regarding medications for TUD. Chi-square tests or Fisher's exact tests were used to examine differences in responses between clinicians and staff who were prescribers versus nonprescribers and to examine factors associated with frequency of prescribing TUD medications. Among 118 survey respondents (56% prescribers), only 50% reported receiving prior training on brief smoking cessation interventions. Examining reported practices identified gaps in the delivery of TUD care, including counseling patients on the impact of smoking on HIV, knowledge of clinical practice guidelines, and implementation of assessment and brief interventions for smoking. Among prescribers, first-line medications for TUD were infrequently prescribed and concerns about medication side effects and interaction with antiretroviral treatments were associated with low frequency of prescribing. HIV clinicians and staff reported addressable gaps in their knowledge, understanding, and practices related to tobacco treatment. Additional work is needed to identify ways to ensure adequate training for providers to enhance the delivery of TUD treatment in HIV clinic settings.
AB - Tobacco use disorder (TUD) is a major threat to health among people with HIV (PWH), but it is often untreated. Among HIV clinicians and staff, we sought to characterize practices, attitudes, and confidence addressing TUD among PWH to identify potential opportunities to enhance provision of care. Cross-sectional deidentified, web-based surveys were administered from November 4, 2020 through December 15, 2020 in HIV clinics in three health systems in the United States Northeast. Surveys assessed provider characteristics and experience, reported practices addressing tobacco use, and knowledge and attitudes regarding medications for TUD. Chi-square tests or Fisher's exact tests were used to examine differences in responses between clinicians and staff who were prescribers versus nonprescribers and to examine factors associated with frequency of prescribing TUD medications. Among 118 survey respondents (56% prescribers), only 50% reported receiving prior training on brief smoking cessation interventions. Examining reported practices identified gaps in the delivery of TUD care, including counseling patients on the impact of smoking on HIV, knowledge of clinical practice guidelines, and implementation of assessment and brief interventions for smoking. Among prescribers, first-line medications for TUD were infrequently prescribed and concerns about medication side effects and interaction with antiretroviral treatments were associated with low frequency of prescribing. HIV clinicians and staff reported addressable gaps in their knowledge, understanding, and practices related to tobacco treatment. Additional work is needed to identify ways to ensure adequate training for providers to enhance the delivery of TUD treatment in HIV clinic settings.
KW - HIV
KW - Implementation science
KW - Nicotine replacement therapy
KW - Smoking
KW - Tobacco
KW - Varenicline
UR - http://www.scopus.com/inward/record.url?scp=85134361039&partnerID=8YFLogxK
U2 - 10.1093/tbm/ibac022
DO - 10.1093/tbm/ibac022
M3 - Article
C2 - 35608982
AN - SCOPUS:85134361039
SN - 1869-6716
VL - 12
SP - 726
EP - 733
JO - Translational Behavioral Medicine
JF - Translational Behavioral Medicine
IS - 6
ER -